Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders
Clinical trial NCT00869323 · TERMINATED
Trial details
- NCT number
- NCT00869323
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2013-03-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.